Showing 1 - 6 of 6
Drugmakers Reap Billions Meeting Covid-19 Needs
Business, Published on 28/02/2022
» Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.
Sinovac makes sense
Oped, Postbag, Published on 20/08/2021
» Re: "Why more Sinovac?," (Editorial, Aug 18).
Deadly drivers
Oped, Postbag, Published on 09/07/2021
» Re: "Anti-vaxxer overload," (PostBag, July 3).
Mass jab hopes a crucial test for Prayut
News, Veera Prateepchaikul, Published on 31/05/2021
» Despite reassurances from Prime Minister Prayut Chan-o-cha and Public Health Minister Anutin Charnvirakul that the mass Covid-19 vaccinations for people over 60 and those suffering from seven non-communicable underlying diseases across the country will proceed as scheduled on June 7, scepticism remains strong among many about whether this administration can still be trusted after repeated blunders in the handling of the pandemic.
Pfizer jab not here yet, says FDA
Gary Boyle, Published on 06/05/2021
» The Food and Drug Administration (FDA) has dismissed a claim made online by ex-prime minister Thaksin Shinawatra in which he said the Pfizer vaccine was already in Thailand for use among a certain group of people.
Indonesian businesses join jab drive
Asia focus, Ismira Lutfia Tisnadibrata, Published on 15/03/2021
» More than 9,000 private companies in Indonesia are gearing up to inoculate their employees and their family members in a bid to revive productivity that has been severely curtailed by the Covid-19 pandemic.